Skip to content
i2E
  • Programs
    • For Startups
      • E3
      • Bridge2
      • OCN
    • For Students
      • Entrepreneur’s Cup
    • For Corporations
    • For Investors
  • Client Portfolio
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Events
  • Contact
  • Media
  • Programs
    • For Startups
      • E3
      • Bridge2
      • OCN
    • For Students
      • Entrepreneur’s Cup
    • For Corporations
    • For Investors
  • Client Portfolio
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Events
  • Contact
  • Media
Search

OU Physician works to develop RSV vaccine

Get in Touch

By Jim Stafford

Copyright  © 2015, The Oklahoma Publishing Company

My voice was raspy as I stepped into the 11th-floor office of Robert Welliver, M.D., at the University of Oklahoma Children’s Physicians tower on the Oklahoma Health Center campus. My nose was runny. I coughed as I sat down.

If I were seeking medical attention for my condition — diagnosed almost two weeks earlier as bronchitis — this would have been exactly the right place. Well, the right place if I were a few decades younger.

Welliver is chief, section of Infectious Diseases, department of Pediatrics at the OU College of Medicine and is on the staff OU Children’s Physicians.

However, it was merely serendipity that brought me to Welliver’s office in such a condition. I was there to interview him about his work in researching respiratory and influenza viruses as an OU physician, professor and scientist.

Welliver is part of an OU team working to develop a vaccine for RSV — respiratory syncytial virus — the bane of infants and their parents worldwide.

“Everyone gets RSV, but the major impact is in infants,” Welliver said. “It’s the most common reason for an infant to be hospitalized.”

Every year about 400 children are hospitalized at OU Children’s with RSV infections. That provides plenty of tissue samples that can be tested with potential vaccines.

“We get samples of secretions from them when they are ill, see what is in there and go back to our models and see if we can manipulate it, make this weaker or this stronger or what effect does this have on the disease,” he said. “The hope is that you will come up with a vaccine that will be a preventative.”

Welliver’s research team is working on its own potential vaccine through a grant from the Oklahoma Center for the Advancement of Science and Technology (OCAST), and also in a separate, sponsored research project for a pharmaceutical company.

Of course, for any vaccine to be effective, parents have to be willing to have their children inoculated. There is growing resistance across the nation to vaccines for both adults and children.

It’s a movement that Welliver dismisses for, well, lack of evidence.

“People are afraid of vaccines and they shouldn’t be,” he said. “I can tell you that the science behind it is overwhelmingly in favor of being vaccinated.”

Welliver came to OU in 2011 from Children’s Hospital in Buffalo, N.Y. The opportunity to pursue scientific research in addition to treat patients and teach medical students was a big draw.

“I think OU is a great place for clinical care,” he said. “But what makes you, as a medical center, stand out is what you are doing to advance knowledge, testing and medication and developing new forms of treatment. We are building that here and it’s coming along pretty rapidly now.”

Our interview grew to a close. So I took a shot at what the doctor thought of my condition — without having to make a co-pay. He had seen and heard me for more than 30 minutes.

Apparently, my condition matched the flu virus, even though I didn’t test positive for it two weeks earlier.

“Flu is a nasty infection,” he said. “As you and I get older, our immune systems don’t clear the infection as quickly as it might.”

With that, I closed my notebook and with a cough backed out of the room. No handshake or knuckle bump. We waved goodbye.

 Jim Stafford writes about the state’s life sciences industry on behalf of the Oklahoma Bioscience Association.

Read the article at newsok.com

 

 

More News

Loading...
Blog, Featured, News
12.16.24

MidAmerica and i2E Announce Award Winners

Read more
Blog, Featured, News
11.21.24

i2E & Plains Ventures Surpasses $100M Milestone in Total Investments

Read more
Blog
09.30.24

i2E Receives 2024 Excellence in Economic Development Award from IEDC

Read more
Blog
06.18.24

Bridge2 Demo Day Returns, Highlighting Promising Oklahoma Startups

Read more
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
05.13.24

Student Entrepreneurs Triumph at 20th Anniversary Entrepreneur’s Cup, Winning $158,000 in Prizes

Read more
Default Featured Image
Blog, Entrepreneur's Cup News
04.24.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – Jessica Kinsey

Read more
Default Featured Image
Blog, Entrepreneur's Cup News
04.23.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – Nathan Fountain

Read more
Default Featured Image
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
04.23.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – Srijita Ghosh

Read more
Default Featured Image
Blog, Entrepreneur's Cup Featured, Entrepreneur's Cup News
04.18.24

Beyond the Cup: Tracking Success Stories from the Entrepreneur’s Cup Series – MaxQ

Read more
Blog, i2E
01.30.24

i2E Celebrates Success of Inaugural Bridge2 Demo Day

Read more
Blog, i2E, News
12.18.23

i2E and MidAmerica Industrial Park announce award winners for high school entrepreneurship program

Read more
Blog, i2E
12.13.23

Entrepreneur’s Cup Marks 20 Years: Reimagined Competition and Brand – Same Entrepreneurial Spirit

Read more
i2E

Oklahoma City Office

201 Robert S Kerr Ave, Suite 600
Oklahoma City, OK 73102
+1 (405) 235.2305

Tulsa Office

12 N. Cheyenne Ave, Suite 112
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources
  • Funding
  • Venture Advisory

© 2025 i2E Privacy Policy

Follow us:

Linkedin Twitter Facebook Instagram Youtube

Programs

  • For Startups
    • E3
    • Bridge2
    • OCN
  • For Students
    • Entrepreneur’s Cup
  • For Corporations
  • For Investors
  • For Startups
    • E3
    • Bridge2
    • OCN
  • For Students
    • Entrepreneur’s Cup
  • For Corporations
  • For Investors
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Events
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E